Efficacy and safety of fremanezumab in patients with migraine and inadequate response to prior preventive treatment: subgroup analyses by country of a randomized, placebo-controlled trial

BACKGROUND: The FOCUS study evaluated the efficacy of migraine preventive medications across different countries within the same patient population, particularly for patients with difficult-to-treat migraine. These prespecified subgroup analyses evaluated efficacy by country in the FOCUS study of fr...

Descripción completa

Detalles Bibliográficos
Autores principales: Spierings, Egilius L. H., Kärppä, Mikko, Ning, Xiaoping, Cohen, Joshua M., Campos, Verena Ramirez, Yang, Ronghua, Reuter, Uwe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8052719/
https://www.ncbi.nlm.nih.gov/pubmed/33863272
http://dx.doi.org/10.1186/s10194-021-01232-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8052719/
https://www.ncbi.nlm.nih.gov/pubmed/33863272
http://dx.doi.org/10.1186/s10194-021-01232-8

Ejemplares similares